These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2436336)

  • 1. Evaluation of p-amidinophenyl esters as potential antithrombotic agents.
    Pizzo SV; Turner AD; Porter NA; Gonias SL
    Thromb Haemost; 1986 Dec; 56(3):387-90. PubMed ID: 2436336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p-Amidino esters as irreversible inhibitors of factors IXa and Xa and thrombin.
    Turner AD; Monroe DM; Roberts HR; Porter NA; Pizzo SV
    Biochemistry; 1986 Aug; 25(17):4929-35. PubMed ID: 3490273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic efficacy of thrombin inhibitor L-374,087: intravenous activity in a primate model of venous thrombus extension and oral activity in a canine model of primary venous and coronary artery thrombosis.
    Cook JJ; Gardell SJ; Holahan MA; Sitko GR; Stump GL; Wallace AA; Gilberto DB; Hare TR; Krueger JA; Dyer DL; Sanderson PE; Vacca JP; Shafer JA; Lynch JJ
    J Pharmacol Exp Ther; 1999 Apr; 289(1):503-10. PubMed ID: 10087043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are factor Xa inhibitors superior to thrombin inhibitors in anticoagulation?
    Stürzebecher J; Stürzebecher U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):152-6. PubMed ID: 2459011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic effects due to pharmacological modulation of thrombin-activatable fibrinolysis inhibitor in rats.
    Soni H; Sharma A; Bhatt S; Jain MR; Patel PR
    Pharmacology; 2008; 82(4):304-9. PubMed ID: 18936552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonpeptide factor Xa inhibitors III: effects of DPC423, an orally-active pyrazole antithrombotic agent, on arterial thrombosis in rabbits.
    Wong PC; Crain EJ; Watson CA; Zaspel AM; Wright MR; Lam PY; Pinto DJ; Wexler RR; Knabb RM
    J Pharmacol Exp Ther; 2002 Dec; 303(3):993-1000. PubMed ID: 12438519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low molecular weight heparins prevent thrombin-induced thrombo-embolism in mice despite low anti-thrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition.
    Momi S; Nasimi M; Colucci M; Nenci GG; Gresele P
    Haematologica; 2001 Mar; 86(3):297-302. PubMed ID: 11255277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N alpha-arylsulfonyl-omega-amidinophenyl-alpha-aminoalkyl-carboxylic acid amides as specific thrombin inhibitors.
    Stürzebecher J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):83-8. PubMed ID: 6177613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synthetic inhibitors of serine proteinases. 2. Inhibitory effect of amidino benzoic acid homologues and of their esters in comparison with trypsin, plasmin and thrombin].
    Walsmann P; Markwardt F; Richter P; Stürzebecher J; Wagner G; Landmann H
    Pharmazie; 1974 May; 29(5):333-6. PubMed ID: 4277282
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of purified factor Xa amidolytic activity may not be predictive of inhibition of in vivo thrombosis: implications for identification of therapeutically active inhibitors.
    Sinha U; Lin PH; Edwards ST; Wong PW; Zhu B; Scarborough RM; Su T; Jia ZJ; Song Y; Zhang P; Clizbe L; Park G; Reed A; Hollenbach SJ; Malinowski J; Arfsten AE
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1098-104. PubMed ID: 12750119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synthetic inhibitors of serine proteinases. 3. Inhibitory effect of basic ally substituted phenyl carbonic acid esters in comparison with trypsin, plasmin and thrombin].
    Stürzebecher J; Markwardt F; Richter P; Wagner G; Walsmann P; Landmann H
    Pharmazie; 1974 May; 29(5):337-8. PubMed ID: 4277283
    [No Abstract]   [Full Text] [Related]  

  • 13. Antithrombotic potential of GW813893: a novel, orally active, active-site directed factor Xa inhibitor.
    Abboud MA; Needle SJ; Burns-Kurtis CL; Valocik RE; Koster PF; Amour AJ; Chan C; Brown D; Chaudry L; Zhou P; Patikis A; Patel C; Pateman AJ; Young RJ; Watson NS; Toomey JR
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):66-71. PubMed ID: 18645410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of a glycoprotein from Gastrodia elata: its effects of anticoagulation and antithrombosis].
    Ding CS; Shen YS; Li G; Wei Z; Wei F
    Zhongguo Zhong Yao Za Zhi; 2007 Jun; 32(11):1060-4. PubMed ID: 17672344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of benzamidine-type thrombin inhibitors.
    Hauptmann J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):89-97. PubMed ID: 6177614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aromatic tetra-amidines: antiproteolytic and antiesterolytic activities towards serine proteinases involved in blood coagulation and clot lysis.
    Ferroni R; Menegatti E; Orlandini P; Guarneri M; Taddeo U; Bolognesi M; Ascenzi P; Bertollini A; Amiconi G
    Farmaco Sci; 1986 Jun; 41(6):464-70. PubMed ID: 3527742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of tris-hydroxymethylaminomethane on reversing coagulation abnormalities caused by acidosis in pigs.
    Martini WZ; Dubick MA; Wade CE; Holcomb JB
    Crit Care Med; 2007 Jun; 35(6):1568-74. PubMed ID: 17452929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant and antithrombotic activity of maltodapoh, a novel sulfated tetrasaccharide.
    Martin DJ; Toce JA; Anevski PJ; Tollefsen DM; Abendschein DR
    J Pharmacol Exp Ther; 1999 Feb; 288(2):516-21. PubMed ID: 9918553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
    Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ
    Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of melagatran, a new low-molecular-weight thrombin inhibitor, on thrombin and fibrinolytic enzymes.
    Gustafsson D; Antonsson T; Bylund R; Eriksson U; Gyzander E; Nilsson I; Elg M; Mattsson C; Deinum J; Pehrsson S; Karlsson O; Nilsson A; Sörensen H
    Thromb Haemost; 1998 Jan; 79(1):110-8. PubMed ID: 9459334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.